Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
Euformatics, Oncompass Medicine, and Institut Curie this month received €1 million through Eurostars to fund the effort, which will run through 2026.
The total budget for the European Innovation Council-backed effort, called PICO-NGS, is €3.5 million.
The starter kit is the first outcome of the €40 million Genomic Data Infrastructure project, which commenced last year.
The Newcastle-on-Tyne-based firm was recently awarded a trio of grants in the UK to further develop its technology and raised £2 million in a seed round.
The firm recently received a European Innovation Council grant worth €5.7 million, and is planning further clinical validation of its platform while it eyes a US entry as soon as next year.
Mobvec will see the development of a new kind of mobile laboratory to support public health responses to vector-borne diseases.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is now poised to launch a microarray-based test for urinary tract infections.
The five-year, EU-funded project, called MensEndoDiag, will explore the use of menstrual blood as a sample type.
The envisioned test will involve measuring protein biomarkers in samples obtained by liquid biopsy, as well as artificial intelligence-based analysis tools.